Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

Analysts at StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued on Monday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

CALA opened at $0.03 on Monday. The company’s 50 day moving average is $0.02 and its 200-day moving average is $0.03. Calithera Biosciences has a 1-year low of $0.01 and a 1-year high of $0.50.

Institutional Investors Weigh In On Calithera Biosciences

A number of hedge funds have recently made changes to their positions in the stock. Renaissance Technologies LLC boosted its stake in shares of Calithera Biosciences by 13.8% in the 3rd quarter. Renaissance Technologies LLC now owns 114,555 shares of the biotechnology company’s stock valued at $337,000 after purchasing an additional 13,855 shares in the last quarter. Vanguard Group Inc. boosted its position in Calithera Biosciences by 23.4% during the 3rd quarter. Vanguard Group Inc. now owns 141,217 shares of the biotechnology company’s stock worth $415,000 after buying an additional 26,800 shares during the period. Goldman Sachs Group Inc. boosted its position in Calithera Biosciences by 143.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 123,739 shares of the biotechnology company’s stock worth $50,000 after buying an additional 72,865 shares during the period. Alyeska Investment Group L.P. acquired a new stake in Calithera Biosciences during the 1st quarter worth approximately $404,000. Finally, Affinity Asset Advisors LLC acquired a new stake in Calithera Biosciences during the 1st quarter worth approximately $404,000.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.